Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, MRCP (Medicine), FRCP (Glasgow)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
General Physician
M.B.B.S., MRCGP (UK)
Pulmonologist
M.B.B.S., F.C.P.S., Fellowship in Pulmonology, MRCP
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCP, Fellowship of Gastroentology, ESEGH
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCP, Fellowship of Gastroentology, ESEGH
Sleep Medicine Doctor
M.B.B.S., M.R.C.P
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures